Article Sidebar

Submitted
26 July 2017
Accepted
26 July 2017
Published
8 August 2017
Download
PDF
Statistic
Read Counter : 1163 Download : 1369

Main Article Content

Abstract

Peripheral arterial disease (PAD) is usually caused by multilevel atherosclerotic disease, typically in patients with a history of cigarette smoking, diabetes mellitus, or both. Intermittent claudication (IC), an early manifestation of PAD, commonly leads to reduced quality of life for patients who are limited in their ambulation. Percutaneous intervention for peripheral artery disease has evolved from balloon angioplasty for simple focal lesions to multimodality techniques that enable treatment of severe arterial insufficiency. Especially for high-grade stenoses or short arterial occlusions, percutaneous transluminal angioplasty (PTA) should be the method of first choice followed by the best surgical procedure later on. To achieve good long-term efficacy, a close follow-up including objective tests of both the arterial lesion and hemodynamic status, surveillance of secondary preventive measures and risk factor control is mandatory.

Keywords

peripheral arterial disease intermittent claudication percutaneous transluminal angioplasty

Article Details

License

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Oktaviono, Y. H. (2017). Case Report: ENDOVASCULAR STENTING IN PERIPHERAL ARTERIAL DISEASE OF LOWER EXTREMITY. Folia Medica Indonesiana, 52(2), 140–147. https://doi.org/10.20473/fmi.v52i2.5231
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Almahameed A and Bhatt DL (2006). Contemporary management of peripheral arterial disease: III. Endovascular and surgical management. Cleveland Clinic Journal of Medicine 73, S45-51
  2. Brunner MC and Caralis DG (2005). Endovascular strategies for management of claudication and lower extremity arterial disease. In: Caralis DG and Bakris GL (eds). Lower Extremity Arterial Disease, New Jersey, Humana Press Inc, p 257-268
  3. Caulfield MT, Fernando D, Rosenfield K (2005). Renal and iliac intervention. In: Herrmann HC (ed). Interventional Cardiology: Percutaneous Noncoronary Intervention, New Jersey, Humana Press Inc, p 295-320
  4. Creager MA, White CJ, Hiatt WR, Criqui MH, Josephs SC, Alberts MJ, Pearce WH, Gray BH, Rocha-Singh KJ (2008). Atherosclerotic peripheral vascular disease symposium II. Circulation 118, 2811-2825
  5. Gianluca R and Paolo C (2012). Iliac artery stenosis. In: Nguyen TN, Hu D, Chen SL, Kim MH, Saito S, Grines CL, Gibson CM, Bailey SR (eds). Practical Handbook of Advanced Interventional Cardiology: Tips and Tricks, 3rd ed, New Jersey, John Wiley & Sons Ltd, p 421-438
  6. Heuser RR and Henry M (2008). Textbook of Peripheral Vascular Interventions, 2nd ed, London, Informa Healthcare
  7. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA (2006). ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 113, e463-e654
  8. Liapis CD and Tzortzis EA (2004). Advances in the management of iliac artery occlusive disease: a short review. Vascular and Endovascular Surgery 38, 541-545
  9. MacNeill BD and Rosenfield (2005). Peripheral intervention. In: Baim DS (ed). Grossman's Cardiac Catheterization, Angiography, and Intervention, 7th ed, Philadelphia, Lippincott Williams & Wilkins, p 562-603
  10. Mahmud E, Cavendish J, Salami A (2007). Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. Journal of the American College of Cardiology 50, 473-490
  11. Mahmud E, Cavendish JJ, Salami A (2007). Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50, 473-490
  12. Mousa AY, Beauford RB, Flores L, Faries PL, Patel P, Fogler R (2007). Endovascular treatment of iliac occlusive disease: review and update. Vascular 15, 5–11
  13. Nguyen LL (2007). Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation. J Vasc Surg 45, A149-A157
  14. Singh K (2003). Percutaneous ilio-femoral revascularizations. In: Nguyen TN, Hu D, Saito S, Grines CL, Palacios I (eds). Practical Handbook of Advanced Interventional Cardiology, 2nd ed, New Jersey, John Wiley & Sons Ltd, p 427-429
  15. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, DeCarlo M, Erbel R, Fowkes FGR, Heras M (2011). ESC guidelines on the diagnosis and treatment of peripheral artery diseases. European Heart Journal 32, 2851-2906
  16. Tsetis D and Uberoi R (2008).Quality improvement guidelines for endovascular treatment of iliac artery occlusive disease. Cardiovasc Intervent Radiol 31, 238-245